Compare Global X FTSE Southeast Asia ETF (ASEA) vs CVS Health Corp (CVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X FTSE Southeast Asia ETF vs CVS Health Corp — how do they compare? Global X FTSE Southeast Asia ETF trades at $21.47, while CVS Health Corp trades at $93.57 (market cap $119.58B). The key difference: CVS Health Corp pays a 2.84% dividend while Global X FTSE Southeast Asia ETF pays none, and Global X FTSE Southeast Asia ETF is trading nearer its 52-week high, CVS Health Corp nearer its low. Which is the better fit depends on your goals.
| ASEA | CVS | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $21.53 | $110.60 |
52-Week Low | $16.86 | $65.51 |
Market Cap | — | $119.58B |
Enterprise Value | — | $181.93B |
Dividend Yield | — | 2.84% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X FTSE Southeast Asia ETF
ASEA tracks the performance of the largest companies in Southeast Asia. It provides exposure to key emerging markets including Singapore, Indonesia, Thailand, and Malaysia, with a heavy focus on financials like DBS Group and Bank Central Asia.
Read more on ASEA →About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →
